Current Ratio of Enveric Biosciences, Inc. from 31 Mar 2012 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Enveric Biosciences, Inc. quarterly Current Ratio in x history and change rate from 31 Mar 2012 to 31 Dec 2025.
- Enveric Biosciences, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 3.94x, a 1.2% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Enveric Biosciences, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 3.94x | +0.05x | +1.2% | 31 Dec 2025 |
| Q3 2025 | 3.04x | -0.45x | -13% | 30 Sep 2025 |
| Q2 2025 | 3.12x | +0.69x | +29% | 30 Jun 2025 |
| Q1 2025 | 4.19x | +2.27x | +118% | 31 Mar 2025 |
| Q4 2024 | 3.9x | +1.81x | +87% | 31 Dec 2024 |
| Q3 2024 | 3.5x | +0.76x | +28% | 30 Sep 2024 |
| Q2 2024 | 2.43x | -1.61x | -40% | 30 Jun 2024 |
| Q1 2024 | 1.92x | -3.69x | -66% | 31 Mar 2024 |
| Q4 2023 | 2.09x | -5.43x | -72% | 31 Dec 2023 |
| Q3 2023 | 2.74x | -5.68x | -67% | 30 Sep 2023 |
| Q2 2023 | 4.04x | -4.77x | -54% | 30 Jun 2023 |
| Q1 2023 | 5.61x | -4.71x | -46% | 31 Mar 2023 |
| Q4 2022 | 7.51x | -5.18x | -41% | 31 Dec 2022 |
| Q3 2022 | 8.41x | -6.57x | -44% | 30 Sep 2022 |
| Q2 2022 | 8.81x | +5.25x | +148% | 30 Jun 2022 |
| Q1 2022 | 10.32x | +8.63x | +512% | 31 Mar 2022 |
| Q4 2021 | 12.69x | +11.92x | +1551% | 31 Dec 2021 |
| Q3 2021 | 14.98x | +14.42x | +2583% | 30 Sep 2021 |
| Q2 2021 | 3.55x | +3.05x | +599% | 30 Jun 2021 |
| Q1 2021 | 1.68x | +1.17x | +228% | 31 Mar 2021 |
| Q4 2020 | 0.77x | +0.21x | +38% | 31 Dec 2020 |
| Q3 2020 | 0.56x | -0.16x | -22% | 30 Sep 2020 |
| Q2 2020 | 0.51x | -0.26x | -34% | 30 Jun 2020 |
| Q1 2020 | 0.51x | -0.11x | -17% | 31 Mar 2020 |
| Q4 2019 | 0.56x | +0.03x | +6% | 31 Dec 2019 |
| Q3 2019 | 0.72x | +0.23x | +48% | 30 Sep 2019 |
| Q2 2019 | 0.77x | +0.36x | +87% | 30 Jun 2019 |
| Q1 2019 | 0.62x | +0.16x | +34% | 31 Mar 2019 |
| Q4 2018 | 0.52x | +0x | +0.94% | 31 Dec 2018 |
| Q3 2018 | 0.49x | -0.09x | -16% | 30 Sep 2018 |
| Q2 2018 | 0.41x | -0.34x | -45% | 30 Jun 2018 |
| Q1 2018 | 0.46x | -0.36x | -44% | 31 Mar 2018 |
| Q4 2017 | 0.52x | -0.33x | -39% | 31 Dec 2017 |
| Q3 2017 | 0.58x | -0.29x | -33% | 30 Sep 2017 |
| Q2 2017 | 0.75x | -0.17x | -19% | 30 Jun 2017 |
| Q1 2017 | 0.82x | -0.08x | -8.7% | 31 Mar 2017 |
| Q4 2016 | 0.85x | -0.12x | -13% | 31 Dec 2016 |
| Q3 2016 | 0.87x | -0.15x | -15% | 30 Sep 2016 |
| Q2 2016 | 0.92x | -0.58x | -39% | 30 Jun 2016 |
| Q1 2016 | 0.9x | -0.82x | -48% | 31 Mar 2016 |
| Q4 2015 | 0.97x | -0.74x | 31 Dec 2015 | |
| Q3 2015 | 1.02x | -0.7x | -41% | 30 Sep 2015 |
| Q2 2015 | 1.51x | +0.83x | 30 Jun 2015 | |
| Q1 2015 | 1.73x | -1.51x | -47% | 31 Mar 2015 |
| Q4 2014 | 1.72x* | -50.22x | 31 Dec 2014 | |
| Q3 2014 | 1.71x | -49.85x | 30 Sep 2014 | |
| Q2 2014 | 0.68x* | -122.3x | 30 Jun 2014 | |
| Q1 2014 | 3.24x | -155.53x | 31 Mar 2014 | |
| Q4 2013 | 51.94x* | -160.53x | 31 Dec 2013 | |
| Q3 2013 | 51.56x* | -192.69x | 30 Sep 2013 | |
| Q2 2013 | 122.98x | -19.73x | -14% | 30 Jun 2013 |
| Q1 2013 | 158.77x* | +158.21x | 31 Mar 2013 | |
| Q4 2012 | 212.47x* | 31 Dec 2012 | ||
| Q3 2012 | 244.25x | 30 Sep 2012 | ||
| Q2 2012 | 142.71x | 30 Jun 2012 | ||
| Q1 2012 | 0.56x* | 31 Mar 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.